"10.1371_journal.pone.0116775","plos one","2015-01-15T00:00:00Z","Jonas Christian Schupp; Harald Binder; Benedikt Jäger; Giuseppe Cillis; Gernot Zissel; Joachim Müller-Quernheim; Antje Prasse","Department of Pneumology, University Medical Centre, Freiburg, Germany; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany; Respiratory Diseases Section, Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy","Conceived and designed the experiments: JCS JMQ AP. Performed the experiments: JCS BJ GC. Analyzed the data: JCS HB AP. Contributed reagents/materials/analysis tools: HB GZ JMQ AP. Wrote the paper: JCS HB JMQ GZ AP.","JMQ, AP and GZ have a patent EP 2011/060641 24.06.2011 Blockade of CCL18 signalling via CCR6 as a therapeutic option in fibrotic diseases and cancer pending. AP received lecture fees from Intermune, Boehringer Ingelheim and consultancy fees for Novartis, Aventis-Sanofi. Antje Prasse and Gernot Zissel are PLOS ONE Editorial Board members. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria. All other authors report no conflicts of interest.","2015","01","Jonas Christian Schupp","JCS",7,TRUE,3,3,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
